Universal Ibogaine Inc. (TSXV:IBO)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Feb 2, 2026, 9:30 AM EST
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of CAD 1.56 million as of October 20, 2026. It is the 49,242nd most valuable company in the world and the 2,363rd biggest in Canada. Its market cap has decreased by 79.72% in one year.
Market Cap
1.56M
Enterprise Value
4.01M
Revenue
2.06M
Global Rank
Country Rank
#2,363 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 34.23M to 1.56M, a decrease of -95.43%. That is a compound annual growth rate of -51.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.13M | 100.00% |
| Dec 31, 2025 | 1.56M | 1.38% |
| Dec 31, 2024 | 1.54M | 60.91% |
| Dec 28, 2023 | 958.97K | -66.61% |
| Dec 30, 2022 | 2.87M | -87.94% |
| Dec 31, 2021 | 23.82M | -30.41% |
| Oct 5, 2021 | 34.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 5.01M |
| Restart Life Sciences | 4.38M |
| Grey Matters Health | 3.84M |
| Innovotech | 3.54M |
| Quest PharmaTech | 3.38M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.06M |
| MindBio Therapeutics | 910.38K |